Palladium MOP Compounds
Organometallics, Vol. 23, No. 18, 2004 4253
calculated positions (C-H ) 0.95 Å, B(H) ) 1.3/1.5B(Cbonded
)
3.51 (b, 1 H, H-L7), 3.33 (s, OCH3), 2.65 (s, CH3-L8), 2.53 (s,
CH3-L9), 1.08 (s, 18 H, C(CH3)3), 0.91 (s, 18 H, C(CH3)3). 13C
NMR (CD2Cl2, 125 MHz): δ 155.6 (C-6), 151.6 (C-L1), 148.3
(C-L6), 138.8 (C-L2), 134.5 (C-2), 130.4 (C-4), 128.9 (C-3), 127.7
(C-10), 124.4 (C-L3), 123.3 (C-L4), 121.8 (C-L5), 121.6 (C-1),
113.8 (C-5), 73.2 (C-L7), 56.3 (OCH3), 50.6 (C-L8), 50.2 (C-L9),
35.1 (C(CH3)3), 34.7 (C(CH3)3), 31.3 (C(CH3)3), 31.2 (C(CH3)3).
31P NMR (CD2Cl2, 202 MHz): δ 49.6 (bs). MS (MALDI): 932.4
(M+ - Cl, 100%).
For all of the chloride abstraction reactions that follow,
below, NMR monitoring shows the reaction to be essentially
quantitative. The weight losses arise from handling the
relatively small amounts of noncrystalline material.
(Å2)), was included in the refinement using a riding model.
Upon convergence (see Table S1), the final Fourier difference
map showed no significant peaks. No extinction correction was
deemed necessary. The scattering factors used, corrected for
the real and imaginary parts of the anomalous dispersion, were
taken from the literature.30 The standard deviations on
intensities were calculated in terms of statistics alone. Refining
the Flack’s parameter tested the handedness of the structure
(cf. Table 6).31 All calculations were carried out by using the
PC versions of the SHELX-9729and ORTEP programs.32
Syn th eses. The syntheses of the complexes 10, 12, and 16
gave products that contained very small (ca. 1%) quantities
of phosphine oxide.
Syn th esis of [P d (C6H4CH2NMe2)(1b)](BAr F ), 12. A 60
mg amount of 10 (0.081 mmol) and 71.4 mg of NaBArF (0.081
mmol) were stirred for 30 min at room temperature in 3 mL
of CH2Cl2. Filtration over Celite and washing with 0.5-1.0 mL
of dichloromethane was followed by removal of the solvent to
Syn th esis of [P d (1b)]2(BF 4), 9. To a mixture of 20 mg of
33
[Pd2(CH3CN)6](BF4)2 (0.032 mmol) and 29.6 mg of 1b (0.063
mmol) was added 1.5 mL of CH3CN and the red solution
stirred for 20 min. After removal of the solvent, the residue
was precipitated from a CH2Cl2/ether solution and washed
twice with ether. Recrystallization from CH2Cl2/ether gave 20
mg (47%) of 9 as a red crystalline material. Anal. Calcd for
give 92 mg (72%) of the product. Anal. Calcd for C74H49NOBF24
-
PPd: C, 56.53; H, 3.14; N, 0.89. Found: C, 57.40; H, 3.29; N,
0.94. 1H NMR (CD2Cl2, 500 MHz): δ 7.88 (d, 3J HH ) 9.0, H-4),
3
3
7.61 (d, J HH ) 8.3, H-10), 7.44 (H-4), 7.27 (H-9), 6.98 (t, J HH
C
66H50O2B2F8P2Pd2‚C2H4Cl2: C, 57.37; H, 3.83. Found: C,
3
57.32; H, 4.86. 1H NMR (CD2Cl2, 500 MHz): δ 8.15 (d, 3J HH
)
) 7.7, H-8), 6.86 (d, J HH ) 7.3, H-L5), 6.72 (H-L4), 6.48 (bd,
3J HH ) 8.1, H-7), 6.16 (t, J HH ) 7.9, H-L3), 5.94 (t, J HH
)
3
3
8.7, H-14), 8.01 (m, Phenyl-H, 2 H), 7.82-7.89 (m, Phenyl-H,
3 H), 7.70 (m, H-15), 7.76 (m, H-4), 7.60-7.67 (m, Phenyl-H, 5
4J PH ) 7.1, H-L2), 4.56 (d, J HH ) 14.1, H-L7), 3.48 (dd, J HH
2
2
4
4
3
4
3
) 13.7, J PH ) 3.6, H-L7), 3.39 (s, OCH3), 2.91 (d, J PH ) 3.2,
H), 7.53 (dt, J HH ) 7.6, J HH ) 0.8, H-19), 7.24 (dt, J HH
)
CH3-L8), 2.86 (d, J PH ) 1.1, CH3-L9). 13C NMR (CD2Cl2, 125
4
4
3
4
7.9, J HH ) 1.0, H-18), 6.83 (dt, J HH ) 7.9, J HH ) 1.1, H-8),
3
3
MHz): δ 155.5 (C-6), 146.8 (C-L6), 140.9 (C-L1), 138.3 (C-L2),
132.8 (C-4), 132.7 (C-2), 132.2 (C-3), 128.4 (C-10), 127.5 (C-8),
127.0 (C-7), 126.7 (C-9), 126.5 (C-L3), 125.8 (C-L4), 125.2 (C-
1), 124.0 (C-L5), 70.6 (C-L7), 65.8 (OCH3), 51.6 (C-L8), 50.3
(C-L9). 31P NMR (CD2Cl2, 202 MHz): δ 39.6 (s). MS (ESI):
707.50 (M+ - BArF, 90%).
Syn th esis of [P d (C6H4CH2NMe2)(1b′)](BAr F ), 13. A 50
mg amount of 11 (0.052 mmol) and 45.7 mg of NaBArF (0.052
mmol) were stirred for 30 min at room temperature in 3 mL
of CH2Cl2. Filtration over Celite and washing with 0.5-1.0 mL
of dichloromethane was followed by removal of the solvent to
6.72 (t, J HH ) 7.9, H-9), 6.69 (d, J HH ) 8.4, H-7), 6.48 (d,
3J HH ) 8.7, H-17), 6.39 (d, J HH ) 8.1, H-10), 5.69 (d, J HH
)
3
3
7.2, H-5), 3.16 (s, OCH3, 3 H). 13C NMR (CD2Cl2, 125 MHz):
δ 142.3 (C-11), 139.4 (C-16), 136.7 (C-6), 136.6 (C-13), 133.2
(C-14), 132.5 (C-8), 131.8 (C-12), 131.6 (C-2), 129.9 (C-18),
129.9 (C-9), 129.0 (C-20), 127.9 (C-15), 127.2 (C-10), 126.0
(C-7), 125.2 (C-17), 123.4 (C-3), 99.7 (C-1), 85.0 (C-4), 79.4
(C-5), 57.6 (OCH3). 31P NMR (CD2Cl2, 202 MHz): δ 38.4 (s).
Syn th esis of P d Cl(C6H4CH2NMe2)(1b), 10. To a mixture
of 88.3 mg of [Pd(µ-Cl)(C6H4CH2NMe2)]2 (0.16 mmol) and 150
mg of 1b (0.32 mmol) was added 4 mL of CH2Cl2. The solution
was stirred for 30 min at room temperature. After removal of
the solvent, the crude product was recrystallized from toluene/
pentane to give 143 mg (60%) of the product. Anal. Calcd for
give 61 mg (65%) of the product. Anal. Calcd for C90H81NOBF24
-
PPd: C, 60.16; H, 4.54; N, 0.78. Found: C, 60.22; H, 4.74; N,
0.79. 1H NMR (CD2Cl2, 500 MHz): δ 7.89 (d, 3J HH ) 9.0, H-4),
3
3
7.62 (d, J HH ) 8.3, H-10), 7.46 (H-5), 7.25 (H-9), 6.81 (d, J HH
C
42H37NOPClPd: C, 67.75; H, 5.01; N, 1.88. Found: C, 68.33;
3
3
1
3
) 7.1, H-L5), 6.67 (t, J HH ) 7.3, H-L4), 6.52 (d, J HH ) 8.3,
H-7), 6.04 (t, J HH ) 7.7, H-L3), 5.76 (t, J HH
H, 5.69; N, 1.78. H NMR (CD2Cl2, 500 MHz): δ 7.64 (d, J HH
) ca. 9.2, H-4), 7.64 (d, J HH ) ca. 9.2, H-10), 7.24 (d, J HH
8.6, H-7), 7.19 (H-9), 7.08 (H-8), 6.82 (d, J HH ) 7.3, H-L5),
6.78 (H-5), 6.65 (t, 3J HH ) 7.5, H-L4), 6.15 (t, 3J HH ) 7.7, H-L3),
6.08 (t, 3J HH ) 6.8, H-L2), 3.78 (d, 4J PH ) 1.3, 2 H, H-L7), 3.40
)
4J PH ) 7.1,
2
3
3
3
3
)
2
3
H-L2), 4.54 (d, J HH ) 13.3, 1 H, H-L7), 3.49 (dd, J HH ) 13.5,
4J PH ) 3.4, 1 H, H-L7), 3.39 (s, OCH3), 2.94 (s, CH3-L8), 2.85
(s, CH3-L9), 1.08 (s, 18 H, C(CH3)3), 1.00 (s, 18 H, C(CH3)3).
13C NMR (CD2Cl2,125 MHz): δ 155.2 (C-6), 146.0 (C-L6), 141.6
(C-L1), 138.4 (C-L2), 133.2 (C-2), 133.0 (C-4), 131.9 (C-3), 128.5
(C-10), 126.4 (C-9), 126.4 (C-7), 126.3 (C-L3), 125.7 (C-L4),
125.4 (C-1), 123.6 (C-L5), 119.5 (C-5), 70.6 (C-L7), 65.8 (OCH3),
51.6 (C-L8), 50.0 (C-L9), 35.1 (C(CH3)3), 34.8 (C(CH3)3), 31.2
(C(CH3)3), 31.1 (C(CH3)3). 31P NMR (CD2Cl2, 202 MHz): δ 43.8
(s). MS (ESI): 932.19 (M+ - BArF, 100%).
4
4
(s, OCH3), 2.68 (d, J PH ) 2.5, CH3-L8), 2.67 (d, J PH ) 2.5,
CH3-L9). 13C NMR (CD2Cl2, 125 MHz): δ 154.7 (C-6), 151.8
(C-L1), 148.8 (C-L6), 138.5 (C-L2), 134.6 (C-2), 130.6 (C-4),
129.1 (C-3), 127.6 (C-10), 127.2 (C-7), 124.5 (C-L3), 123.6 (C-
L4), 122.2 (C-L5), 119.9 (C-1), 112.2 (C-5), 73.4 (C-L7), 55.3
(OCH3), 50.8 (C-L8), 50.6 (C-L9). 31P NMR (CD2Cl2, 202
MHz): δ 48.1 (s). MS (MALDI): 708.1 (M+ - Cl, 100%).
Syn th esis of P d Cl(C6H4CH2NMe2)(1b′), 11. To a mixture
of 59.7 mg of [Pd(µ-Cl)(C6H4CH2NMe2)]2 (0.108 mmol) and 150
mg of 1b′ (0.216 mmol) was added 4 mL of CH2Cl2. The
solution was stirred for 30 min at room temperature. The
solvent was distilled off to give a quantitative yield of the
product. Anal. Calcd for C58H69NOPClPd: C, 71.89; H, 7.18;
Syn th esis of [P d (C6H4CH2NMe2)(1a )](BAr F ), 16. A 50
mg amount of 14 (0.070 mmol) and 62 mg of NaBArF (0.070
mmol) were stirred for 30 min at room temperature in 2 mL
of CH2Cl2. Filtration over Celite and washing with 0.5-1.0 mL
of dichloromethane was followed by removal of the solvent to
give 58 mg (54%) of the product. Anal. Calcd for C73H47NBF24
-
1
PPd: C, 56.85; H, 3.07; N, 0.91. Found: C, 57.76; H, 3.21; N,
N, 1.45. Found: C, 71.93; H, 7.23; N, 1.39. H NMR (CD2Cl2,
0.99. 1H NMR (CD2Cl2, 500 MHz): δ 8.20 (d, 3J HH ) 8.6, H-4),
3
3
500 MHz): δ 7.63 (d, J HH ) 8.3, H-4), 7.63 (d, J HH ) 8.3,
3
3
3
7.84 (d, J HH ) 8.3, H-10), 7.81 (dd, J HH ) 8.8 and 6.2, H-5),
7.34 (H-9), 7.25 (H-6), 6.80 (H-L5), 6.67 (H-L4), 6.66 (H-8), 6.21
H-10), 6.89 (b, H-5), 6.69 (H-L5), 6.54 (t, J HH ) 7.5, H-L4),
6.00 (t, J HH ) 7.5, H-L3), 5.80 (b, H-L2), 3.65 (b, 1 H, H-L7),
3
3
3
4
(t, J HH ) 7.7, H-L3), 6.15 (t, J HH ) J PH ) 7.7, H-L2), 6.11
(d, 3J HH ) 8.3, H-7), 4.56 (d, 2J HH ) 13.3, H-L7), 3.45 (dd, 2J HH
(30) International Tables for X-ray Crystallography; Wilson, A. J .
C., Ed.; Kluwer Academic Publisher: Dordrecht, The Netherlands,
1992; Vol. C.
(31) Flack, H. D. Acta Crystallogr. 1983, A 39, 876.
(32) Farrugia, L.J . J . Appl. Crystallogr. 1997, 30, 565.
(33) Murahashi, T.; Nagai, T.; Okuno, T.; Matsutani, T.; Kurosawa,
H. Chem. Commun. 2000, 1689-1690.
4
4
) 13.3, J PH ) 2.1, H-L7), 3.12 (bd, J PH ) 2.8, CH3-L8), 2.58
(s, CH3-L9). 13C NMR (CD2Cl2,125 MHz): δ 149.4 (C-L1), 149.2
(C-1), 145.1 (C-L6), 137.6 (C-L2), 134.5 (C-3), 132.0 (C-2), 131.3
(C-4), 129.5 (C-9), 128.3 (C-10), 128.0 (C-8), 127.5 (C-7), 127.5
(C-5), 127.4 (C-L3), 126.0 (C-L4), 124.4 (C-L5), 106.6 (C-6), 72.8